Inventor
MAK TAK W
CA25 patents
⚠️ This page may combine multiple inventors who share the name “MAK TAK W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ONTARIO CANCER INST
11 patentsUS5557032ASep 17, 1996
Knockout mice
ONTARIO CANCER INST104 citations98
US5616491AApr 1, 1997
Knockout mice
ONTARIO CANCER INST58 citations96
US5731490AMar 24, 1998
Mutant mouse lacking the expression of interferon regulatory factor 1 (IRF-1)
ONTARIO CANCER INST29 citations92
US5698765ADec 16, 1997
Mouse having a disrupted CD4 gene
ONTARIO CANCER INST35 citations92
US5625122AApr 29, 1997
Mouse having a disrupted lck gene
ONTARIO CANCER INST41 citations92
US4923799AMay 8, 1990
T cell specific cDNA clone
ONTARIO CANCER INST27 citations92
US4713332ADec 15, 1987
T cell specific CDNA clone
ONTARIO CANCER INST29 citations92
US5684222ANov 4, 1997
Mutant mouse having a disrupted TNFRp55
ONTARIO CANCER INST7 citations73
US5532158AJul 2, 1996
Interleukin-2 receptor deficient mammals
ONTARIO CANCER INST6 citations73
US5530178AJun 25, 1996
Mutant mouse lacking CD8 surface marker
ONTARIO CANCER INST14 citations73
US5675059AOct 7, 1997
Mouse lacking the expression of interferon regulatory factor 2 (IRF-2)
ONTARIO CANCER INST0 citations52
UNIV HEALTH NETWORK
8 patentsUS11766437B2Sep 26, 2023
Combination therapies for inhibition of TTK protein kinase
UNIV HEALTH NETWORK0 citations59
US9493561B2Nov 15, 2016
Antibodies to Toso
UNIV HEALTH NETWORK2 citations55
US10822388B2Nov 3, 2020
Methods and compositions for modulating toso activity
UNIV HEALTH NETWORK0 citations51
US9670265B2Jun 6, 2017
Methods and compositions for modulating toso activity
UNIV HEALTH NETWORK0 citations51
US9624289B2Apr 18, 2017
Methods and compositions for modulating Toso activity
UNIV HEALTH NETWORK0 citations51
US9321824B2Apr 26, 2016
Methods and compositions for modulating Toso activity
UNIV HEALTH NETWORK0 citations51
US9228006B2Jan 5, 2016
Methods and compositions for modulating Toso activity
UNIV HEALTH NETWORK0 citations51
US10533222B2Jan 14, 2020
Methods and compositions for detection of targets for autoimmune disease
UNIV HEALTH NETWORK0 citations31
AMGEN CANADA INC
3 patentsUS6468528B1Oct 22, 2002
Materials and methods to inhibit Hodgkin and Reed Sternberg cell growth
AMGEN CANADA INC67 citations93
US5907079AMay 25, 1999
MSH2 disrupted mice develop lymphomas
AMGEN CANADA INC57 citations91
US7312024B2Dec 25, 2007
Materials and methods to inhibit Hodgkin and Reed Sternberg cell growth
AMGEN CANADA INC26 citations89